Is MannKind Corp (MNKD) overvalued? · rev $285.5M
MannKind Corp (MNKD) is a biotechnology company listed on US.
This page asks whether MannKind Corp (MNKD) looks expensive on cached numbers — not a short thesis.
Latest reported MNKD revenue for 2024-12-31 was $285.5M. Net income was $27.6M. Revenue was up 43.5% from 2023-12-31 to 2024-12-31. MNKD currently screens at market cap $1.28B.
MNKD currently screens at market cap $1.28B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MNKD 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MNKD stock page for the full model, not this heading.
Not investment advice.